Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMWG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,225
Award facts
- Contract value 100% obligated
- $49,224.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $49,224.90 to DMS Pharmaceutical Group Inc. for the supply of Keytruda (pembrolizumab) 100 mg/4 ml vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 17, 2025. This delivery order was issued without a set-aside designation, allowing the company to compete on an unrestricted basis despite its small business status. The contract represents a single pharmaceutical product delivery supporting the Defense Logistics Agency's mission to provision medical supplies to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent success in securing delivery orders for specialty medications and oncology treatments to support military health facilities nationwide. The Keytruda delivery order reflects the company's established role in distributing high-value pharmaceutical products to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FNMWG?
SPE2DB25FNMWG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FNMWG worth?
The government has obligated $49,225 on SPE2DB25FNMWG.
Is contract SPE2DB25FNMWG an order under another contract?
Yes. SPE2DB25FNMWG is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMWG competed?
The extent of competition for SPE2DB25FNMWG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award